Hans Scheffel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hans Scheffel has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Paul Stolzmann
University Hospital Zürich
5 shared publicationsHatem Alkadhi
Institute of Diagnostic Radiology, University Hospital Zurich, Raemistr. 100, 8091 Zurich, Switzerland
4 shared publicationsBorut Marincek
Institute of Diagnostic Radiology, University Hospital Zurich, Raemistr. 100, 8091 Zurich, Switzerland
3 shared publicationsOlivio F. Donati
University Hospital Zürich
3 shared publicationsSebastian Leschka
Institute of Diagnostic Radiology, University Hospital Zurich, Raemistr. 100, 8091 Zurich, Switzerland
3 shared publicationsAndré Plass
Clinic for Cardiovascular Surgery, University Hospital Zurich, Switzerland
2 shared publications
Latest Publications
- Open Access
- 9 November 2010
- Published by Springer Nature in BMC Medical Imaging
- Vol. 10 (1) , 25
Absent cervical spine pedicle and associated congenital spinal abnormalities - a diagnostic trap in a setting of acute trauma: case report
Congenital spinal abnormalities can easily be misdiagnosed on plain radiographs. Additional imaging is warranted in doubtful cases, especially in a setting of acute trauma.
- 9 November 2010
- Published by Springer Nature in BMC Medical Imaging
- Vol. 10 (1) , 25
Open AccessAbsent cervical spine pedicle and associated congenital spinal abnormalities - a diagnostic trap in a setting of acute trauma: case report
Congenital spinal abnormalities can easily be misdiagnosed on plain radiographs. Additional imaging is warranted in doubtful cases, especially in a setting of acute trauma.
- 18 August 2010
- Published by Springer Nature in European Radiology
- Vol. 21 (2) , 246-255
Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT
- 18 August 2010
- Published by Springer Nature in European Radiology
- Vol. 21 (2) , 246-255
Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT
- Open Access
- 1 April 2010
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 10 (4) , 513-518
Coronary artery disease in patients with cardiac tumors: preoperative assessment by computed tomography coronary angiography☆
We studied the diagnostic accuracy of computed tomography coronary angiography (CTCA) for the diagnosis of significant coronary artery disease (CAD) compared to conventional coronary angiography (CCA) in patients with primary cardiac tumors. Thirty-eight consecutive patients with primary cardiac tumors (27 females, 11 males; mean age 56±6 years, range 32–86 years) underwent dual-source CTCA and CCA. Significant stenosis was defined as diameter reduction >50%. CCA served as the standard of reference. The prevalence of significant CAD in the study population was 8% (3/38 patients). Five of 544 segments (0.9%) in 1/38 patients (2.6%) was considered of non-diagnostic image quality on CTCA because of motion artifacts. In a segment-based analysis taking not-evaluative segments as false-positive, sensitivity, specificity, positive and negative predictive value of CT was 100%, 99%, 70%, and 100%, respectively. Preoperative CCA could have been avoided in 95% (36/38) of the patients and CCA would have confirmed the CTCA diagnosis in 5% (2/38) of the patients. Our results indicate that CTCA provides a high diagnostic performance for diagnosing significant CAD in patients with primary cardiac tumors. CTCA may thus be used as a filter test prior to surgery.
- 1 April 2010
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 10 (4) , 513-518
Open AccessCoronary artery disease in patients with cardiac tumors: preoperative assessment by computed tomography coronary angiography☆
We studied the diagnostic accuracy of computed tomography coronary angiography (CTCA) for the diagnosis of significant coronary artery disease (CAD) compared to conventional coronary angiography (CCA) in patients with primary cardiac tumors. Thirty-eight consecutive patients with primary cardiac tumors (27 females, 11 males; mean age 56±6 years, range 32–86 years) underwent dual-source CTCA and CCA. Significant stenosis was defined as diameter reduction >50%. CCA served as the standard of reference. The prevalence of significant CAD in the study population was 8% (3/38 patients). Five of 544 segments (0.9%) in 1/38 patients (2.6%) was considered of non-diagnostic image quality on CTCA because of motion artifacts. In a segment-based analysis taking not-evaluative segments as false-positive, sensitivity, specificity, positive and negative predictive value of CT was 100%, 99%, 70%, and 100%, respectively. Preoperative CCA could have been avoided in 95% (36/38) of the patients and CCA would have confirmed the CTCA diagnosis in 5% (2/38) of the patients. Our results indicate that CTCA provides a high diagnostic performance for diagnosing significant CAD in patients with primary cardiac tumors. CTCA may thus be used as a filter test prior to surgery.
- 10 February 2010
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 26 (5) , 579-590
Low-dose CT and cardiac MR for the diagnosis of coronary artery disease: accuracy of single and combined approaches
To prospectively compare the diagnostic performance of low-dose computed tomography coronary angiography (CTCA) and cardiac magnetic resonance imaging (CMR) and combinations thereof for the diagnosis of significant coronary stenoses. Forty-three consecutive patients with known or suspected coronary artery disease underwent catheter coronary angiography (CA), dual-source CTCA with prospective electrocardiography-gating, and cardiac CMR (1.5 Tesla). The following tests were analyzed: (1) low-dose CTCA, (2) adenosine stress-rest perfusion-CMR, (3) late gadolinium enhancement (LGE), (4) perfusion-CMR and LGE, (5) low-dose CTCA combined with perfusion-CMR, (5) low-dose CTCA combined with late gadolinium-enhancement, (6) low-dose CTCA combined with perfusion-CMR and LGE. CA served as the standard of reference. CA revealed >50% diameter stenoses in 68/129 (57.7%) coronary arteries in 29/43 (70%) patients. In the patient-based analysis, sensitivity, specificity, NPV and PPV of low-dose CTCA for the detection of significant stenoses were 100, 92.9, 100 and 96.7%, respectively. For perfusion-CMR and LGE, sensitivity, specificity, NPV, PPV, and accuracy were 89.7, 100, 82.4, and 100%, respectively. In the artery-based analysis, sensitivity and NPV of low-dose CTCA was significantly (P < 0.05) higher than that of perfusion-CMR and LGE. All combinations of low-dose CTCA and perfusion-CMR and/or LGE did not improve the diagnostic performance when compared to low-dose CTCA alone. Taking CA as standard of reference, low-dose CTCA outperforms CMR with regard to sensitivity and NPV, whereas CMR is more specific and has a higher PPV than low-dose CTCA.
- 10 February 2010
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 26 (5) , 579-590
Low-dose CT and cardiac MR for the diagnosis of coronary artery disease: accuracy of single and combined approaches
To prospectively compare the diagnostic performance of low-dose computed tomography coronary angiography (CTCA) and cardiac magnetic resonance imaging (CMR) and combinations thereof for the diagnosis of significant coronary stenoses. Forty-three consecutive patients with known or suspected coronary artery disease underwent catheter coronary angiography (CA), dual-source CTCA with prospective electrocardiography-gating, and cardiac CMR (1.5 Tesla). The following tests were analyzed: (1) low-dose CTCA, (2) adenosine stress-rest perfusion-CMR, (3) late gadolinium enhancement (LGE), (4) perfusion-CMR and LGE, (5) low-dose CTCA combined with perfusion-CMR, (5) low-dose CTCA combined with late gadolinium-enhancement, (6) low-dose CTCA combined with perfusion-CMR and LGE. CA served as the standard of reference. CA revealed >50% diameter stenoses in 68/129 (57.7%) coronary arteries in 29/43 (70%) patients. In the patient-based analysis, sensitivity, specificity, NPV and PPV of low-dose CTCA for the detection of significant stenoses were 100, 92.9, 100 and 96.7%, respectively. For perfusion-CMR and LGE, sensitivity, specificity, NPV, PPV, and accuracy were 89.7, 100, 82.4, and 100%, respectively. In the artery-based analysis, sensitivity and NPV of low-dose CTCA was significantly (P < 0.05) higher than that of perfusion-CMR and LGE. All combinations of low-dose CTCA and perfusion-CMR and/or LGE did not improve the diagnostic performance when compared to low-dose CTCA alone. Taking CA as standard of reference, low-dose CTCA outperforms CMR with regard to sensitivity and NPV, whereas CMR is more specific and has a higher PPV than low-dose CTCA.
- 8 January 2010
- Vol. 11 (1) , 49-54
Intraductal oncocytic papillary neoplasm of the pancreas: a radio-pathological case study.
An intraductal oncocytic papillary neoplasm is a rare pancreatic tumor with the potential of developing invasive carcinoma. Its differentiation from other cystic-like neoplasms of the pancreas, such as intraductal papillary mucinous neoplasms, is a challenge for pancreatic imaging. We present the case of a 76-year-old male with painless jaundice caused by an intraductal oncocytic papillary neoplasm of the pancreas. The imaging findings on computed tomography, magnetic resonance including diffusion-weighted imaging, and (18)F-fluorodeoxyglucose positron emission tomography are presented and the radio-pathological correlations are discussed. An intraductal oncocytic papillary neoplasm of the pancreas appears as a cystic tumor communicating with the dilated pancreatic duct featuring intraductal tumor nodules. Intraductal oncocytic papillary neoplasms show a high (18)F-fluorodeoxyglucose-uptake in positron emission tomography and low diffusion values in diffusion-weighted imaging including apparent diffusion coefficient maps which may be a valuable attribute in distinguishing these rare lesions from intraductal papillary mucinous neoplasms.
- 8 January 2010
- Vol. 11 (1) , 49-54
Intraductal oncocytic papillary neoplasm of the pancreas: a radio-pathological case study.
An intraductal oncocytic papillary neoplasm is a rare pancreatic tumor with the potential of developing invasive carcinoma. Its differentiation from other cystic-like neoplasms of the pancreas, such as intraductal papillary mucinous neoplasms, is a challenge for pancreatic imaging. We present the case of a 76-year-old male with painless jaundice caused by an intraductal oncocytic papillary neoplasm of the pancreas. The imaging findings on computed tomography, magnetic resonance including diffusion-weighted imaging, and (18)F-fluorodeoxyglucose positron emission tomography are presented and the radio-pathological correlations are discussed. An intraductal oncocytic papillary neoplasm of the pancreas appears as a cystic tumor communicating with the dilated pancreatic duct featuring intraductal tumor nodules. Intraductal oncocytic papillary neoplasms show a high (18)F-fluorodeoxyglucose-uptake in positron emission tomography and low diffusion values in diffusion-weighted imaging including apparent diffusion coefficient maps which may be a valuable attribute in distinguishing these rare lesions from intraductal papillary mucinous neoplasms.
- 11 November 2009
- Published by Springer Nature in Herz
- Vol. 34 (7) , 562-563
Magnetic Resonance Imaging of Cardiac Contusion
- 11 November 2009
- Published by Springer Nature in Herz
- Vol. 34 (7) , 562-563
Magnetic Resonance Imaging of Cardiac Contusion
- 30 April 2008
- Published by Elsevier in Academic Radiology
- Vol. 15 (4) , 452-461
Comparison of Diagnostic Accuracy of 64-Slice Computed Tomography Coronary Angiography in Patients with Low, Intermediate, and High Cardiovascular Risk
- 30 April 2008
- Published by Elsevier in Academic Radiology
- Vol. 15 (4) , 452-461
Comparison of Diagnostic Accuracy of 64-Slice Computed Tomography Coronary Angiography in Patients with Low, Intermediate, and High Cardiovascular Risk
- 1 March 2007
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 17 (1) , 41-47
Metastases in Meckel's Cave
- 1 March 2007
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 17 (1) , 41-47
Metastases in Meckel's Cave
- 1 December 2006
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 16 (4) , 254-257
Sphenoid Sinus Epidermoid Cyst
- 1 December 2006
- Published by Springer Nature in Clinical Neuroradiology
- Vol. 16 (4) , 254-257
Sphenoid Sinus Epidermoid Cyst